Therapy: Biosimilars in rheumatology - why, how and when in 2017
- PMID: 29097811
- DOI: 10.1038/nrrheum.2017.179
Therapy: Biosimilars in rheumatology - why, how and when in 2017
Comment on
-
Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases.Ann Rheum Dis. 2018 Feb;77(2):165-174. doi: 10.1136/annrheumdis-2017-211937. Epub 2017 Sep 2. Ann Rheum Dis. 2018. PMID: 28866648
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources